Jupiter Wellness Reports Positive Efficacy Results from Clinical Study for its NoStingz Topical Jellyfish Protection Sunscreen
JUPITER, FL, Aug. 09, 2023 (GLOBE NEWSWIRE) -- Jupiter Wellness, Inc. (Nasdaq: JUPW), a diversified company that supports health and wellness, today announced data from a recent clinical study of NoStingz, its proprietary topical sunscreen formulated to protect users from jellyfish, sea lice, and UVA/UVB rays.
- JUPITER, FL, Aug. 09, 2023 (GLOBE NEWSWIRE) -- Jupiter Wellness , Inc. (Nasdaq: JUPW ), a diversified company that supports health and wellness, today announced data from a recent clinical study of NoStingz, its proprietary topical sunscreen formulated to protect users from jellyfish, sea lice, and UVA/UVB rays.
- Portuguese man-o’-war, a marine hydrozoan closely related to jellyfish, has a powerful sting that has been known to kill humans.
- The present in vivo study used Portuguese man-o’-war (MOW) gathered from the Atlantic Ocean near Key West, Florida.
- “This latest data confirms prior clinical study results and what we’ve been hearing from happy customers about NoStingz—it works,” stated Jupiter Wellness CEO Brian John.